|
US30985A
(en)
|
|
1860-12-18 |
|
Thomas l |
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
CA1341423C
(en)
|
1984-10-31 |
2003-03-04 |
Paul A. Luciw |
Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
EP0281604B1
(en)
|
1986-09-02 |
1993-03-31 |
Enzon Labs Inc. |
Single polypeptide chain binding molecules
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
EP0387319B1
(en)
|
1988-07-23 |
1996-03-06 |
Delta Biotechnology Limited |
Secretory leader sequences
|
|
ATE135397T1
(de)
|
1988-09-23 |
1996-03-15 |
Cetus Oncology Corp |
Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
US5972650A
(en)
|
1997-06-26 |
1999-10-26 |
Brigham And Women's Hospital |
Tetracycline repressor regulated mammalian cell transcription and viral replication switch
|
|
US6022952A
(en)
|
1998-04-01 |
2000-02-08 |
University Of Alberta |
Compositions and methods for protein secretion
|
|
US6210924B1
(en)
|
1998-08-11 |
2001-04-03 |
Amgen Inc. |
Overexpressing cyclin D 1 in a eukaryotic cell line
|
|
JP4475814B2
(ja)
|
1998-11-20 |
2010-06-09 |
扶桑薬品工業株式会社 |
タンパク質発現ベクターとその使用
|
|
AU4010400A
(en)
|
1999-03-18 |
2000-10-04 |
Human Genome Sciences, Inc. |
27 human secreted proteins
|
|
US20050005310A1
(en)
|
1999-07-12 |
2005-01-06 |
Genentech, Inc. |
Expression vectors and methods
|
|
GB2355459B
(en)
|
1999-11-29 |
2001-09-26 |
Isis Innovation |
A dominant conditional lethal genetic system
|
|
DK1332222T3
(da)
|
2000-11-03 |
2009-07-06 |
Genentech Inc |
Stofskifteændringer i fermenteringer der udtrykker rekombinante proteiner
|
|
WO2004046340A2
(en)
|
2002-11-14 |
2004-06-03 |
Genentech, Inc. |
Intron fusion construct and method of using for selecting high-expressing production cell lines
|
|
US7824907B2
(en)
|
2003-03-11 |
2010-11-02 |
Merck Serono Sa |
Expression vectors comprising the mCMV IE2 promoter
|
|
GB2404382B
(en)
|
2003-07-28 |
2008-01-30 |
Oxitec Ltd |
Pest control
|
|
CN1867350A
(zh)
|
2003-08-14 |
2006-11-22 |
惠氏公司 |
重组润滑素分子及其用途
|
|
KR20050022071A
(ko)
|
2003-08-26 |
2005-03-07 |
삼성에스디아이 주식회사 |
플라즈마 디스플레이 패널
|
|
US20080032300A1
(en)
|
2004-12-02 |
2008-02-07 |
Laboratories Serono S.A. |
Lupac Bifunctional Marker and Its Use in Protein Production
|
|
WO2006063292A1
(en)
|
2004-12-08 |
2006-06-15 |
Icos Corporation |
Recombinant method for making multimeric proteins
|
|
EP1979376A2
(en)
|
2006-02-03 |
2008-10-15 |
Wyeth a Corporation of the State of Delaware |
Structure lingo-1
|
|
GB2443186A
(en)
|
2006-10-25 |
2008-04-30 |
Oxitec Ltd |
Expression system for mediating alternative splicing
|
|
WO2008020960A1
(en)
|
2006-08-07 |
2008-02-21 |
Avigenics, Inc. |
Hybrid promoters
|
|
FR2910490B1
(fr)
|
2006-12-20 |
2012-10-26 |
Lab Francais Du Fractionnement |
Lignee cellulaire a forte activite transcriptionnelle pour la production de proteines, notamment therapeutiques
|
|
KR100884214B1
(ko)
|
2007-04-04 |
2009-02-19 |
주식회사 마크로젠 |
Ｃａｅｖ-계 벡터 시스템
|
|
MX2009013120A
(es)
|
2007-06-29 |
2010-01-15 |
Hoffmann La Roche |
Promotor.
|
|
PT2592148T
(pt)
|
2007-10-12 |
2018-11-12 |
Hoffmann La Roche |
Expressão proteica de múltiplos ácidos nucleicos
|
|
EP2203180B1
(en)
|
2007-10-22 |
2012-11-21 |
Merck Serono S.A. |
Single ifn-beta fused to a mutated igg fc fragment
|
|
ME03057B
(me)
|
2007-12-07 |
2019-01-20 |
Zymogenetics Inc |
Molekuli humanizovanih antitela specifični za il-31
|
|
US8795981B2
(en)
|
2008-08-08 |
2014-08-05 |
Molecular Devices, Llc |
Cell detection
|
|
US9445581B2
(en)
|
2012-03-28 |
2016-09-20 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
GB201004143D0
(en)
*
|
2010-03-12 |
2010-04-28 |
Isis Innovation |
Promoter sequence for DNA and viral vectors
|
|
JP6055615B2
(ja)
|
2011-05-27 |
2016-12-27 |
アッヴィ バイオテクノロジー リミテッド |
Ｄａｃｈｙｐ組成物および方法
|
|
CA2844662A1
(en)
|
2011-08-08 |
2013-02-14 |
Abbvie Biotherapeutics Inc. |
Methods of treating progressive forms of multiple sclerosis
|
|
US20140295497A1
(en)
|
2011-11-30 |
2014-10-02 |
Taymar E. Hartman |
Vectors and host cells comprising a modified sv40 promoter for protein expression
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
SG10201900915WA
(en)
|
2011-12-22 |
2019-03-28 |
Hoffmann La Roche |
Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
|
|
US9567577B2
(en)
|
2012-03-12 |
2017-02-14 |
Ares Trading S.A. |
Expression vector comprising a polynucleotide encoding a modified glutamine synthetase and a method for preparing a target protein employing the same
|
|
US8945553B2
(en)
|
2012-05-22 |
2015-02-03 |
Bristol-Myers Squibb Company |
Bispecific antibodies to IL-23 and IL-17A/F
|
|
EP2674495A1
(en)
|
2012-06-14 |
2013-12-18 |
Sanofi |
CHO expression system
|
|
EP2711428A1
(en)
|
2012-09-21 |
2014-03-26 |
Lonza Biologics plc. |
Site-specific integration
|
|
CN112522353A
(zh)
|
2012-10-10 |
2021-03-19 |
中外制药株式会社 |
经修饰的宿主细胞的建立方法
|
|
US9290552B2
(en)
|
2012-12-21 |
2016-03-22 |
Dna Twopointo, Inc. |
Fluorescent and colored proteins and methods for using them
|
|
AU2014225272B2
(en)
|
2013-03-08 |
2015-10-22 |
Neuclone Biologics Pty Ltd |
A cell expression system
|
|
EP3683314A1
(en)
|
2013-10-07 |
2020-07-22 |
Prestige Biopharma Pte. Ltd. |
Bicistronic expression vector for antibody expression and method for producing antibody using same
|
|
US10344285B2
(en)
|
2014-04-09 |
2019-07-09 |
Dna2.0, Inc. |
DNA vectors, transposons and transposases for eukaryotic genome modification
|
|
DK3129487T3
(da)
|
2014-04-09 |
2020-11-30 |
Dna Twopointo Inc |
Forbedrede nukleinsyrekonstruktioner til eukaryot genekspression
|
|
US12534502B2
(en)
|
2016-10-04 |
2026-01-27 |
Svar Life Science Ab |
FGF21 responsive reporter gene cell line
|
|
US11280790B2
(en)
|
2016-10-04 |
2022-03-22 |
Svar Life Science Ab |
System and products for improved quantification of ADCC activity
|